Status:
UNKNOWN
Relationship Between Methods of Bladder Tumor Extraction and Local Recurrence Rate
Lead Sponsor:
I.M. Sechenov First Moscow State Medical University
Conditions:
Bladder Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
According to clinical guidelines, endoscopic surgery (mono- or bipolar TURBT, laser resection, en bloc resection) is a standard treatment option for patients with primary non-muscle invasive bladder c...
Eligibility Criteria
Inclusion
- Patients scheduled for endoscopic bladder tumor removal
- Non-muscle invasive bladder cancer on contrast-enhanced MRI or CT (stage cT1N0M0 and lower)
- Diameter of tumor \>3cm
Exclusion
- Patient refused to participate in the trial
- Multiple (more than 2) bladder tumors
- Previous cold-cup biopsy or any other surgery for bladder tumor
- Muscle-invasive bladder cancer on postoperative histological evaluation
- Other malignant/benign tumors of the bladder (non-urothelial cancer)
Key Trial Info
Start Date :
January 11 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 11 2022
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT04750590
Start Date
January 11 2021
End Date
June 11 2022
Last Update
February 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Urology and Reproductive Health, Sechenov University.
Moscow, Russia, 119991